92 related articles for article (PubMed ID: 21938013)
1. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
van der Fits L; Out-Luiting JJ; van Leeuwen MA; Samsom JN; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2012 Feb; 132(2):440-7. PubMed ID: 21938013
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192
[TBL] [Abstract][Full Text] [Related]
3. Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome.
van der Fits L; Out-Luiting JJ; Tensen CP; Zoutman WH; Vermeer MH
J Invest Dermatol; 2014 Oct; 134(10):2639-2647. PubMed ID: 24756111
[TBL] [Abstract][Full Text] [Related]
4. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
[TBL] [Abstract][Full Text] [Related]
6. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G
Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.
McKenzie RC; Jones CL; Tosi I; Caesar JA; Whittaker SJ; Mitchell TJ
Leukemia; 2012 Feb; 26(2):323-31. PubMed ID: 21818116
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques.
Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C
Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosis.
Ghazi B; Thonnart N; Bagot M; Bensussan A; Marie-Cardine A
J Invest Dermatol; 2015 Jan; 135(1):229-237. PubMed ID: 25007046
[TBL] [Abstract][Full Text] [Related]
12. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
Foss FM; Koc Y; Stetler-Stevenson MA; Nguyen DT; O'Brien MC; Turner R; Sausville EA
J Clin Oncol; 1994 Feb; 12(2):326-35. PubMed ID: 8113839
[TBL] [Abstract][Full Text] [Related]
13. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
Strengell M; Julkunen I; Matikainen S
J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
[TBL] [Abstract][Full Text] [Related]
15. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
16. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
van der Fits L; Sandberg Y; Darzentas N; Zoutman WH; Tielemans D; Wolvers-Tettero IL; Vermeer MH; Langerak AW
Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
18. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
Suchin KR; Cassin M; Gottleib SL; Sood S; Cucchiara AJ; Vonderheid EC; Rook AH
J Am Acad Dermatol; 2001 Jan; 44(1):28-32. PubMed ID: 11148473
[TBL] [Abstract][Full Text] [Related]
20. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
